AI Drug Discovery Breakthrough + Insilico Phase 2 Success & 31% Better Cancer Detection

Insilico Medicine announces its AI-designed anti-fibrotic drug has entered Phase 2 clinical trials in just 18 months — far faster than the industry average. We also cover: • Recursion Pharmaceuticals reporting 12 new clinical-stage drug candidates generated by its AI platform in the past year • Pfizer and Tempus partnering to use AI for matching cancer patients with personalized clinical trials • A new NEJM study showing AI-assisted diagnostic tools improved early cancer detection rates by 31% in routine screenings

Episode metadata supplied by the publisher feed · Published Apr 11, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

AI Drug Discovery Breakthrough + Insilico Phase 2 Success & 31% Better Cancer Detection

0:00 5:17

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

CISO Perspectives (public) N2K Networks This season on CISO Perspectives, host Kim Jones explores some of the challenges of leading through uncertainty. We explore the complexity of the changing nature of regulation and working with the federal government, the evolution of privacy and fraud, and how emerging technologies like AI and quantum computing are changing cyber. When you don’t know what questions to ask, you’re afraid to ask, or don’t know who to ask, CISO Perspectives provides the foundation for learning in this brave new world.

Frequently Asked Questions

How long is this episode of AI First Pod?

This episode is 5 minutes long.

When was this AI First Pod episode published?

This episode was published on April 11, 2026.

Can I download this AI First Pod episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!